经皮冠状动脉介入治疗中冠状动脉内阿昔单抗的研究综述——我们现在的进展和未来的发展方向?

Recent patents on cardiovascular drug discovery Pub Date : 2013-12-01 DOI:10.2174/15748901113089990021

Sanjiv Sharma, Kumud Bhalla, Sarabjeet Singh

{"title":"经皮冠状动脉介入治疗中冠状动脉内阿昔单抗的研究综述——我们现在的进展和未来的发展方向?","authors":"Sanjiv Sharma, Kumud Bhalla, Sarabjeet Singh","doi":"10.2174/15748901113089990021","DOIUrl":null,"url":null,"abstract":"The rationale for intracoronary administration of abciximab is discussed. The data on use of intracoronary abciximab in percutaneous coronary interventions in acute coronary syndromes and STEMI are reviewed. Evaluation of the niche where intracoronary administration of abciximab may be useful and future research into the subject and relevant patents are discussed. ","PeriodicalId":20905,"journal":{"name":"Recent patents on cardiovascular drug discovery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"A review of intracoronary abciximab in percutaneous coronary interventions--where are we now and where do we go from here?\",\"authors\":\"Sanjiv Sharma, Kumud Bhalla, Sarabjeet Singh\",\"doi\":\"10.2174/15748901113089990021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The rationale for intracoronary administration of abciximab is discussed. The data on use of intracoronary abciximab in percutaneous coronary interventions in acute coronary syndromes and STEMI are reviewed. Evaluation of the niche where intracoronary administration of abciximab may be useful and future research into the subject and relevant patents are discussed. \",\"PeriodicalId\":20905,\"journal\":{\"name\":\"Recent patents on cardiovascular drug discovery\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent patents on cardiovascular drug discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/15748901113089990021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on cardiovascular drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/15748901113089990021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

讨论了冠状动脉内给药阿昔单抗的基本原理。本文回顾了急性冠脉综合征和STEMI经皮冠状动脉介入治疗中冠状动脉内使用阿昔单抗的数据。评估阿昔单抗冠状动脉内给药可能有用的利基，并讨论了该主题的未来研究和相关专利。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

A review of intracoronary abciximab in percutaneous coronary interventions--where are we now and where do we go from here?

The rationale for intracoronary administration of abciximab is discussed. The data on use of intracoronary abciximab in percutaneous coronary interventions in acute coronary syndromes and STEMI are reviewed. Evaluation of the niche where intracoronary administration of abciximab may be useful and future research into the subject and relevant patents are discussed.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Recent patents on cardiovascular drug discovery

自引率

0.00%

发文量

期刊最新文献

Patents and Heart Valve Surgery - III: Percutaneous Heart Valves. Patents and Heart Valve Surgery - III: Percutaneous Heart Valves. New frontiers in the management of acute coronary syndromes: cangrelor and elinogrel. Blockade of renin angiotensin system in heart failure post-myocardial infarction: what is the best therapy? Ticagrelor: a novel drug for an old problem.